Covista Inc. vs Stride, Inc., two Education stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CVSA and LRN diverge most: on current ratio, CVSA reads 1.09 and LRN reads 5.94; on revenue growth, CVSA reads +9.3% and LRN reads +5.0%. The rest of the comparable metrics sit closer together. What CVSA's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | CVSA | LRN |
|---|---|---|
| Price | $129.69 | $85.50 |
| Market cap | $4.4B | $3.6B |
| Sector | Education | Education |
| Stage | Mature | Mature |
| P/E | 18.4 | 12.0 |
| P/B | 3.05 | 2.18 |
| P/S | 2.26 | 1.41 |
| EV/EBITDA | 10.7 | 6.6 |
| Revenue growth | +9.3% | +5.0% |
| Gross margin | — | 34.2% |
| Operating margin | 19.0% | 16.6% |
| Net margin | 12.9% | 13.4% |
| Return on equity | 17.4% | 20.7% |
| Return on assets | 8.3% | 13.9% |
| Return on invested capital | 14.8% | 17.4% |
| FCF yield | 8.9% | 12.2% |
| Debt / equity | 0.46 | 0.26 |
| Current ratio | 1.09 | 5.94 |
| Altman Z (solvency) | 3.87 | 5.22 |
| Piotroski F (quality) | 5 / 9 | 6 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.